Compare Biophan Technologies vs Stanmore Implants
Customers evaluate the quality of Biophan Technologies's products using the following success metrics.
Overview
Biophan Technologies is 61 yrs old and is based in United States.
Biophan is dedicated to providing technologies that offer innovative andcompetitive advantages to the medical device industry. The Company ishelping to commercialize the Myotech Circulatory Support System, which has potential to improve the treatment of acute heart failure.Biophan Technologies, Inc. holds a 68% interest in Myotech. Biophan istraded on the OTC market under the symbol BIPH, and is also listed on theFrankfurt Stock Exchange under the symbol BTN.
Stanmore Implants is 75 yrs old and is based in United Kingdom.
Stanmore Implants designs and manufactures implants focused on orthopaedic oncology, and complex primary and revision cases in the upper limb, lower limb and pelvis.
Demo Video
Leadership
Edward F Cowle (Founder)
Michael R. Mainelli (Chief Executive Officer, President)
Investors
U.S. Department of Energy, Cantara
Stryker, Norgine Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Biophan Technologies has not claimed their profile.
Work for Biophan Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Biophan Technologies?
Claim your profile now.
Information not available because Stanmore Implants has not claimed their profile.
Work for Stanmore Implants? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Stanmore Implants?
Claim your profile now.